Gerresheimer AGXSWX:GXI 73 3-Year ROIIC % is 8.14 as of Nov. 2024, which is 132% above its 10-year median of 3.51. GuruFocus rates XSWX:GXI with a GF Score™ of 73/100 and a GF Value™ of CHF87.42 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 58.95% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Gerresheimer AG's 3-Year ROIIC % for the quarter that ended in Nov. 2024 was 8.14%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Gerresheimer AG's 3-Year ROIIC % or its related term are showing as below:
XSWX:GXI's 3-Year ROIIC % is ranked better than 58.95% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.78
vs XSWX:GXI: 8.14
Gerresheimer AG (XSWX:GXI) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Gerresheimer AG 3-Year ROIIC % Related Terms
Gerresheimer AG 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GXI vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Gerresheimer AG (XSWX:GXI) has a 3-Year ROIIC % of 8.14 as of Nov. 2024. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Gerresheimer AG and its competitors. This is 132% above median its historical median of 3.51. According to the industry distribution chart, Gerresheimer AG ranks #328 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 41.1%.
Is Gerresheimer AG's 3-Year ROIIC % too high?
Gerresheimer AG's current 3-Year ROIIC % of 8.14 is 132% above median its 10-year median of 3.51. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.78. Gerresheimer AG's value of 8.14 is 357.3% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #328 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #328 out of 799 companies for 3-Year ROIIC %. This puts Gerresheimer AG in the upper half of its industry. The industry median 3-Year ROIIC % is 1.78. Gerresheimer AG's value of 8.14 is 357.3% above this benchmark. While the company's 10-year median is 3.51 vs. the industry median of 1.78, Gerresheimer AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.78, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current 3-Year ROIIC % of 8.14 is 357.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current 3-Year ROIIC % is 8.14, which is 132% above median its own 10-year median of 3.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.42, compared to a current price of CHF25.02 — trading 71.4% below its estimated fair value. The current 3-Year ROIIC % is 8.14, which is 132% above median its 10-year median of 3.51 and 357.3% above the Medical Devices & Instruments industry median of 1.78. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current 3-Year ROIIC % is 8.14 as of Nov. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.02 is trading 71.4% below its estimated GF Value™ of CHF87.42.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for XSWX:GXI:
3-Year ROIIC %: 8.14 (132% above median its 10-year median of 3.51)
GF Value™: CHF87.42 vs. price of CHF25.02 (71.4% below fair value)
Industry Position: 357.3% above the Medical Devices & Instruments median (#328 of 799)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score
Get the complete analysis for XSWX:GXI
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
